微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 8.05% | 6.91% | 89.41% | 22/69 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 4.25% | -10.9% | 59.77% | 28/69 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 2.66% | -12.5% | -65.09% | 27/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 7.62% | -3.91% | 1.2% | 23/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 7.53% | -14.53% | 57.86% | 21/69 | 2.76% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 4.77% | -18.46% | 56.91% | 24/69 | 0.62% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 3.04% | -24.57% | -61.66% | 24/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 7.93% | 15.09% | -9.99% | 29/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 8.81% | 175.31% | 50.6% | 22/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 5.85% | 34.17% | 45.16% | 23/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 4.03% | 183.8% | -41.51% | 19/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 6.89% | 162.98% | 115.31% | 36/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 3.2% | -22.71% | -26.61% | 49/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 4.36% | -8.4% | 207.04% | 30/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 1.42% | 49.47% | -45.8% | 46/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 2.62% | 670.59% | -36.71% | 53/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 4.14% | -62.77% | -13.03% | 52/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 4.76% | 111.56% | 401.05% | 33/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 0.95% | -75.26% | 179.41% | 56/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 0.34% | 103.88% | -96.94% | 60/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 11.12% | 29.75% | 394.22% | 12/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 2.25% | -63.18% | -41.41% | 46/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 3.84% | 19.63% | 143.84% | 10/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | -8.76% | -167.08% | -202.22% | 62/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 8.57% | -34.68% | 40.26% | 26/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 6.11% | -25.31% | 90.34% | 19/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 3.21% | -29.76% | -75.42% | 23/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 13.06% | -16.28% | -0.46% | 20/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 13.12% | -2.6% | 60.39% | 7/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 8.18% | -5.1% | 78.99% | 9/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 4.57% | 6.28% | -70.71% | 6/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 15.6% | 35.42% | 15.81% | 11/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 13.47% | 32.19% | 56.26% | 10/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 8.62% | 26.21% | 100.47% | 10/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 4.3% | 18.46% | -62.67% | 10/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 11.52% | -18.3% | 13.05% | 28/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 10.19% | -36.79% | 49.19% | 21/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 6.83% | -23.6% | 88.15% | 24/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 3.63% | -17.31% | -74.26% | 22/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 14.1% | 4.14% | -12.53% | 28/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 16.12% | 2.41% | 80.31% | 6/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 8.94% | 9.42% | 103.64% | 12/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 4.39% | -22.71% | -67.58% | 12/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |